简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2011-08-17 16:46 PPD Names Jasmine (Jisong) Cui Chief Scientific Officer of BioDuro
2011-08-12 17:49 Covidien Announces Share Repurchase Program
2011-08-12 08:00 Cegedim Relationship Management Hosts Life Sciences Thought Leadership Events that Focus on Innovation
2011-08-11 13:43 Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis
2011-08-10 09:26 Avery Dennison Medical Solutions to Present Innovative Products & Technologies at MEDTEC China 2011
2011-08-08 22:45 22nd Century Enrolls First Patients in X-22 Phase II-B Smoking Cessation Clinical Trial
2011-08-08 20:30 Welch Allyn Partners with Pelstar, LLC, to Enable Automated Interface between Select Vital Signs Devices and Health o meter® Professional Scales
2011-08-08 17:52 Diversey Releases Annual Global Responsibility Report
2011-08-04 15:15 Quintiles Names Jeffrey Spaeder Chief Medical & Scientific Officer
2011-08-03 20:00 Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV)
2011-08-03 17:05 Quintiles, Kadrige Open E-Solutions Operation in the US
2011-07-29 16:49 University Hospital Wurzburg: The World’s First Heart Patient Treated with Novel MRI Ablation Catheter
2011-07-28 18:12 Covidien Reports Third-Quarter Results
2011-07-25 11:34 BIOTRONIK Vascular Enters U.S. with First Peripheral Stent Implant in BIOFLEX-I IDE Clinical Trial
2011-07-22 15:06 FDA Clears X-22 IND For Phase II-B Smoking Cessation Clinical Trial
2011-07-21 12:15 Covidien Declares Quarterly Cash Dividend
2011-07-20 17:09 Global Top-Fifteen Pharma Company Selects Cegedim Relationship Management’s SaaS Solution for Optimizing Alignment of Sales Forces and Territories
2011-07-15 16:57 KCI Announces Agreement to Be Acquired by Consortium Including Apax Partners, CPPIB and PSP Investments in Transaction Valued at $6.3 Billion
2011-07-15 11:33 BIOTRONIK Announces First Patients Treated in BIOFLOW-II Clinical Study Comparing ORSIRO Hybrid Drug-Eluting Stent to Abbott's XIENCE PRIME™
2011-07-15 10:06 Economist Intelligence Unit, Quintiles Find Innovation is Vital to Future of Biopharma

Business Wire Weibo

Press Releases

Latest Releases